ONCE-DAILY ROFLUMILAST CREAM 0.15% FOR ATOPIC DERMATITIS: POOLED RESULTS: FROM INTEGUMENT-1/2 PHASE 3 TRIALS

被引：0
|
作者：
Eichenfield, L.
Boguniewicz, M.
Simpson, E.
Blauvelt, A.
Gooderham, M.
Lain, E.
Chu, D.
Higham, R.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P284
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [41] Effects of ruxolitinib cream on pruritus and sleep in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, E. L.
    Boguniewicz, M.
    Thaci, D.
    Misery, L.
    Armstrong, A. W.
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Szepietowski, J. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E166 - E167
  • [42] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by anatomic region: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Bissonnette, Robert
    Gold, Linda F. Stein
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB53 - AB53
  • [43] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: pooled results from two phase III studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Ren, H.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E167 - E167
  • [44] Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials
    Paller, Amy S.
    Yosipovitch, Gil
    Tom, Wynnis L.
    Lebwohl, Mark
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Tallman, Anna M.
    Tan, Bill
    Hebert, Adelaide A.
    PEDIATRICS, 2018, 142
  • [45] Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials
    Paller, Amy S.
    Yosipovitch, Gil
    Tom, Wynnis L.
    Lebwohl, Mark
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Tallman, Anna M.
    Tan, Bill
    Hebert, Adelaide A.
    PEDIATRICS, 2018, 142
  • [46] Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies
    Eichenfield, Lawrence F.
    Gold, Linda F. Stein
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Ren, Haobo
    Brar, Kanwaljit K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB180 - AB180
  • [47] Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials
    Desai, Seemal R.
    Gold, Linda Stein
    Cameron, Michael C.
    Golant, Alexandra
    Lewitt, G. Michael
    Bruno, Matthew J.
    Martin, George
    Brown, Philip M.
    Rubenstein, David S.
    Butners, Victoria
    Tallman, Anna M.
    DERMATOLOGY AND THERAPY, 2023, 13 (10) : 2443 - 2460
  • [48] Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials
    Seemal R. Desai
    Linda Stein Gold
    Michael C. Cameron
    Alexandra Golant
    G. Michael Lewitt
    Matthew J. Bruno
    George Martin
    Philip M. Brown
    David S. Rubenstein
    Victoria Butners
    Anna M. Tallman
    Dermatology and Therapy, 2023, 13 : 2443 - 2460
  • [49] Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials
    Bissonnette, Robert
    Strober, Bruce
    Lebwohl, Mark
    Bagel, Jerry
    Del Rosso, James
    Merola, Joseph F.
    Bhatia, Neal
    Yamauchi, Paul
    Brown, Philip M.
    Rubenstein, David S.
    Tallman, Anna M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB71 - AB71
  • [50] Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kallender, Howard
    Sturm, Daniel
    Wang, Mingyue
    Eichenfield, Lawrence F.
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2139 - 2151
12345